The Phyto-Microbiome Company Biological Accelerators for Soil, Seed and Plant Vigor AG INNOVATION SHOWCASE St. Louis, MO September 10, 2014 www.inocucor.com SITUATIONAL BACKDROP ¥  Need to grow food production by 100 percent in <50 years ¥  Large population growth in India, Africa and China ¥  Synthetic chemicals in our drinking water tied to cancer and infertility ¥  1 2 billion people going to bed hungry each day AG Innovation Showcase OUR SOLUTION AND PRODUCT ROADMAP Garden Solution® is a live-cell formulation that interacts with the indigenous ecology—the phytomicrobiome—to improve plant and soil health for traditional and organic farmers Future products are microbial cell-free formulations that offer bio-stimulation and better disease management for largescale production farmers 3 AG Innovation Showcase POWER OF MIXED MICROBIAL COMMUNITIES A Microbial Consor.a, Rather Than Single-‐Species, Approach 4 ¥  Current technologies based on growing single microbes that perform one task, such as disease protection ¥  Inocucor’s technology based on the emerging science of microbial consortia ¥  Microbes work together to stimulate the phytomicrobiome ¥  15 strains produce powerful natural growth optimizers to promote a better balance of the phytomicrobiome AG Innovation Showcase PRODUCT DEVELOPMENT STUDIES Demostrate immediate growth benefits and increase in yield ¥  Increase of 15-20% in seed germination rate in soybeans ¥  Field studies in soybeans show 10-15% higher yield over nutrients only ¥  Greenhouse and field studies in corn show increase in emergence and dry biomass 5 AG Innovation Showcase OVERARCHING VALUE CREATION STRATEGY IP Value Creation Strategy Rapid Commercialization Strategy File IP around multiple solutions Phased multi-channel commercialization Revenue from collaborations, licenses and products Near-term: Key regional early adopters for 1st gen products and “Big Ag” technology collaborations Mid-term: Provide IP Content and supply Key Ingredient for biostimulation and bio-protection products to various industrial platforms Coupled with Strategic Acquisitions Stages Inocucor for liquidity event with multiple shots on goal 6 AG Innovation Showcase FIRST COMMERCIAL COLLABORATION Inocucor Technologies Signs First Commercial Strategic Partnership with Axter Agroscience 7 AG Innovation Showcase INTELLECTUAL PROPERTY STRATEGY ¥  Inocucor’s intellectual property and regulatory strategy are intertwined to ring fence proprietary position ¥  American Type Culture Collection (ATCC ) Patent Depository 8 AG Innovation Showcase OUR TARGET MARKETS AND CUSTOMERS ¥  ¥  Traditional and Organic Agriculture Garden Solution® is used in both traditional and organic farming Production Agriculture Next generation bio-stimulation and bioprotection products are targeted for use by large-scale production farmers Soil Amendments $ Billions CAGR 8.5% $28.9 $17.7 2011 2017 Agricultural Biologicals $ Billions CAGR 20% $7.5 $3.0 Will serve as the main driver of valuation for Inocucor’s stakeholders over the next 4 to 5 years 9 AG Innovation Showcase 2014 2020 LEADERSHIP TEAM ¥  Donald Marvin, MBA – President & CEO ¥  ¥  Margaret Bywater-Ekegard, MD, PhD – Founder; EVP, Tech & Innovation ¥  ¥  Strong background in finance, legal and business development with extensive experience in building successful, high growth technology companies Jan Kral – Vice President, Sales ¥  10 An out-of-the-box thinker and environmentalist, pushing the borders of traditional microbiology through new formulation discovery and artisanal process transfer Bryan Wallis, LLB, MBA – Vice President & CFO ¥  ¥  Molecular pathologist: extensive experience in identifying and successfully commercializing proprietary technologies at several Life Science/Biotech Ananda Lynn Fitzsimmons, Founder; VP, Disc & Process Dev ¥  ¥  Serial entrepreneur and track record of building exceptional value for stakeholders at several Life Science and Agri-food companies An accomplished engineer with the ability to bridge the Sales - R&D function and to open new markets for innovative products AG Innovation Showcase FINANCING STRATEGY AND EXIT A balance of short term revenue opportunities, non-dilutive capital and equity fundraising ¥  Pursue Non-dilutive Capital Opportunities ¥  Launch Series B Equity Financing in the range of $5M - $8M in Q4 2014 ¥  Series C Round - $10 to $15M to Stage Company for Trade Sale or IPO ¥  Establish a Pattern of Liquidity for SH’s within a 4 to 5 year time frame 11 AG Innovation Showcase INVESTMENT THESIS ¥  Versatile ¥  Solid ¥  First technology platform Intellectual Property position and FTO gen product being sold to early adopters ¥  Aggregating leadership in key technologies & IP for broad commercialization ¥  Leadership Team and Board with track record of creating exceptional stakeholder value ¥  Staged 12 for a Trade Sale or IPO AG Innovation Showcase The Phyto-Microbiome Company Biological Accelerators for Soil, Seed and Plant Vigor Contact: Donald Marvin President & CEO [email protected] www.inocucor.com